Article Information
History
- January 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alexa Pichet Binette1,*,
- Nicolai Franzmeier2,*,
- Nicola Spotorno1,
- Michael Ewers2,3,
- Matthias Brendel4,5,
- Davina Biel2,
- ADNI+,
- Olof Strandberg1,
- Shorena Janelidze1,
- Sebastian Palmqvist1,6,
- Niklas Mattsson-Carlgren1,7,8,
- Ruben Smith1,7,
- Erik Stomrud1,6,
- Rik Ossenkoppele1,9 and
- Oskar Hansson1,6,†
- 1Clinical Memory Research Unit, Faculty of Medicine, Lund University, Lund, Sweden
- 2Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
- 3German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
- 4Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
- 5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 6Memory Clinic, Skåne University Hospital, Malmö, Sweden
- 7Department of Neurology, Skåne University Hospital, Lund, Sweden
- 8Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden
- 9Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands
- ↵†Correspondence: oskar.hansson{at}med.lu.se
↵* Contributed equally as first authors with both equally performing analyses, creating figures and drafting the manuscript.
Posted January 08, 2022.
Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer
